10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||||||||||||
| |||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
REGENERON PHARMACEUTICALS, INC. | ||
Ticker: REGN Fiscal Year: 2010 | ||
BALANCE SHEETS | ||
Period Ending Dec 31, 2010 10-K (Filed: Feb 17, 2011) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2010 | Dec 31, 2009 | |
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $ 112,572 | 207,075 |
| Marketable securities | 136,796 | 134,255 |
| Accounts receivable from the sanofi-aventis Group | 79,603 | 62,703 |
| Accounts receivable - other | 13,509 | 2,865 |
| Prepaid expenses and other current assets | 15,142 | 18,610 |
| Total current assets | 357,622 | 425,508 |
| Restricted cash and marketable securities | 7,518 | 1,600 |
| Marketable securities | 370,053 | 47,080 |
| Property, plant, and equipment, at cost, net of accumulated depreciation and amortization | 347,450 | 259,676 |
| Other assets | 6,789 | 7,338 |
| Total assets | 1,089,432 | 741,202 |
| LIABILITIES and STOCKHOLDERS' EQUITY | ||
| Current liabilities | ||
| Accounts payable and accrued expenses | 53,658 | 49,031 |
| Deferred revenue from sanofi-aventis, current portion | 19,506 | 17,523 |
| Deferred revenue - other, current portion | 35,217 | 27,021 |
| Facility lease obligations, current portion | 675 | 0 |
| Total current liabilities | 109,056 | 93,575 |
| Deferred revenue from sanofi-aventis | 97,081 | 90,933 |
| Deferred revenue - other | 188,775 | 46,951 |
| Facility lease obligations | 159,355 | 109,022 |
| Other long term liabilities | 7,350 | 3,959 |
| Total liabilities | 561,617 | 344,440 |
| Commitments and contingencies | ||
| Stockholders' equity | ||
| Preferred stock, $.01 par value; 30,000,000 shares authorized; issued and outstanding-none | 2 | 2 |
| Common Stock | 87 | 79 |
| Additional paid-in capital | 1,575,780 | 1,336,732 |
| Accumulated deficit | (1,045,563) | (941,095) |
| Accumulated other comprehensive (loss) income | (2,491) | 1,044 |
| Total stockholders' equity | 527,815 | 396,762 |
| Total liabilities and stockholders' equity | 1,089,432 | 741,202 |
| External Links | |
| REGENERON PHARMACEUTICALS, INC. (REGN) Fiscal Year 2010 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |